SMAD1 and ganglioneuroma: Moreover, we have shown that administration of anti-PDGFβ-receptor (anti-PDGFβR) antibody (APB5) to the mesangial-proliferative model of GN in Thy1 GN rats attenuates glomerular cell proliferation and glomerulosclerosis and Smad1 activation.